Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials – The Wall Street Journal
Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials The Wall Street JournalView Full Coverage on Google News
Women who give up weight-loss jabs for pregnancy can suffer harmful weight gain
When women taking weight loss jabs stop their use because of pregnancy, the rebound weight gain brings health risks for their babies. Women who paused the injections before or shortly after conceiving were more likely to gain excess weight in pregnancy, a study has found. This made them more likely to develop diabetes or high […]
Best-Performing ETFs of Last Week: Healthcare Rules
Wall Street was downbeat last week. The S&P 500 index lost 1.95%, the Dow Jones index retreated 1.9% and the Nasdaq Composite slumped 2.7%. Overvaluation concerns in the artificial intelligence (AI) space continued to hurt the space. NVIDIA’s NVDA strong quarterly results couldn’t save the market fully in the end. Moreover, there were speculations in […]
New fat jab warning as pregnancy risks revealed, even after stopping use – from ‘premature birth to extra weight gain’
FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such as Wegovy or Mounjaro, but stopped just before pregnancy or in the first trimester were at higher risk of complications. Research by the Mass General Brigham Hospital in the USA found they…
Ozempic Pill Flops in Major Trials for Alzheimer’s
An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease’s progression compared to a placebo.
Lizzo Says Plus-Sized Women Are Being ‘Erased’ Due to Ozempic Boom
The Grammy winner opened up about how the rise of GLP-1 drugs is changing visibility for women who look like her.
The complicated relationship between GLP-1s and pregnancy
A new study sheds light on the risks and benefits of taking GLP-1 weight-loss drugs before having a baby.
People who stop using Mounjaro tend to regain weight and lose other health benefits, says study
Improvements such as reduced ‘bad’ cholesterol and lower blood pressure go into reverse upon stopping weight-loss jabsPeople who stop using the weight-loss jab Mounjaro not only tend to regain weight, but experience a reversal in other health improvements too, research suggests.Mounjaro, which contains the active ingredient tirzepatide, has become a popular medication for weight loss, with studies suggesting that it can help people lose an average of 20% of their body weight after 72 weeks of treatment. Continue reading…
STAT+: Lilly hits trillion-dollar valuation as GLP-1 era peaks
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! We’re closing in on CMS’s deadline for 2027 Medicare-negotiated drug prices. Plus, we see a break from precedent in how the FDA selects priority review vouchers, and more. Can a GLP-1 drug slow Alzheimer’s […]
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in
Eli Lilly LLY briefly crossed the $1 trillion market cap on Nov. 21, 2025 — becoming the first-ever health-care company to join the elite group mainly dominated by tech giants, as mentioned on CNBC. Shares touched around $1,059 on the day. GLP-1 &GIP Leadership Fuels Rally The stock has surged 36.2% this year, mainly backed by […]